We, Changzhou Pharmaceutical Factory is a manufacturer who produce more than 30 kinds APIs and 120 kinds finished formulation. Since 1984, we have approved US FDA audit for 16 times until now.
We have 2 wholly owned subsidiaries: Changzhou Wuxin and Nantong Chanyoo. And Nantong Changzhou also has approved USFDA, EUGMP, PMDA and CFDA audits.
Yes, we could share COA and relevant documents for customer reference.
If customer needs confidential documents, like DMF, it is available after trial order for DMF open part.
This is depends, and we could talk based on the actual order.
This also needs to talk and negotiate based on different projects and different quantity.
Normally, the minimum quantity is 1kg.
Yes, normally, we offer 20g as free sample to support customer.
For small quantity, we could ship by air; and if with tons quantity, we would ship by sea.
You could send an enquiry to this email: firstname.lastname@example.org. After our both sides confirmation, we could confirm the order, and proceed next.
You could send us email: email@example.com.
Or you could make the phone call: +86 519 88821493.
We have already worked with many international customers, like: Novartis, Sanofi, GSK, Astrazeneca, Merck, Roche, Teva, Pfizer, Apotex, Sun Pharma. and ect.
Nantong Chanyoo is our wholly-owned manufacturer by Changzhou Pharmaceutical Factory.
Changzhou Pharmaceutical Factory is one of the core industrial enterprise of Shanghai Pharma. Group.
Yes, we have GMP certificate for Hydrochlorothiazide, Captopril and ect.
Our different products have different certificates, and normally, we have US DMF, US DMF, CEP, WC, PMDA, EUGMP, like: Rosuvastatin.
We have more than 50 honorary titles, like: Top 100 pharmaceutical industrial enterprises in China; Price integrity company; The state designated production enterprise for basic drugs; China AAA level credit company; National excellent API export brand; China HI-tech enterprise; Contract performance and trust worthy company; National demonstration enterprise of drug quality and integrity.
In 2018, we have achieved USD88000. And annual growth rate reach to 5.52%.
Yes, we have 2 R&D centers which are responsible for the development of APIs and finished formulations. We invest 80% of our sales volume into our R&D every year. Currently, our R&D pipeline varieties include 31 generics, 20 APIS, 9 ANDAs and 18 consistency assessment products.
We have 16 workshops for all kinds of products.
We produce 1000+ tons per year.
We expertise at Cardiovascular, Anticancer, Antipyretic analgesic, Vitamin, Antibiotic and Health care medicine engineering, and as called: “Cardio-Cerebrovascular Specialist”.